Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Health Technology Topic Center

Featured Article

News
GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine
06/10/2024
Grace Taylor, MS, MA
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare...
06/10/2024
Journal of Clinical Pathways
AI
News
The Potential for AI in Oncology
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
Best Practices in Care Team Communication Technology: Updates From NCCN 2024
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Nate Wade, PharmD.
Videos
EHR Integration: Strategies to Enhance Precision Medicine
03/25/2024

Featuring Nate Wade, PharmD, MBA, BCOP

Featuring Nate Wade, PharmD, MBA, BCO...
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate...
03/25/2024
Journal of Clinical Pathways
Amy Valley and the AI panel from CPC+CBEx.
News
AI in Cancer Care: Navigating the Current Landscape and Future Possibilities
10/24/2023

Brandon Twyford

Brandon Twyford
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care:...
10/24/2023
Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
The Future of AI in Cancer Care
10/08/2023

Featuring Will Shapiro

Featuring Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
Video preview thumbnail.
Videos
AI Technology in Oncology Care: Thoughts From The Oncology Institute
10/02/2023

Featuring Daniel Virnich, MD; Yale Podnos, MD; and Nikhil Buduma

Featuring Daniel Virnich, MD; Yale Po...
Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...
Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...
Daniel Virnich, MD, CEO of The...
10/02/2023
Journal of Clinical Pathways
Video preview image.
Videos
St. Elizabeth’s Innovative Cancer Screening Outreach Model
09/22/2023

Featuring Michael Gieske, MD, and Jamie Ries, RN, BSN

Featuring Michael Gieske, MD, and Jam...
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie...
09/22/2023
Journal of Clinical Pathways
Clinical Pathways Forum
Precision Medicine Testing in Oncology: Benefits of and Barriers to Adoption
09/19/2023
Mishellene McKinney, MHA, RN, OCN—Column Editor
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical...
09/19/2023
Journal of Clinical Pathways
Stephen Edge, MD.
Videos
Clinical Pathways in Practice at Roswell Park Cancer Center
09/05/2023

Featuring Stephen Edge, MD

Featuring Stephen Edge, MD
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president...
09/05/2023
Journal of Clinical Pathways
Video thumbnail screenshot.
Videos
Using Digital Health to Implement Patient-Reported Outcomes in Cancer Care
08/30/2023

Featuring Claire Snyder, PhD, and Norah Crossnohere, PhD

Featuring Claire Snyder, PhD, and Nor...
Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health, and Norah Crossnohere, PhD, the Ohio State University College of Medicine, discuss their work on implementing patient-reported outcome measures into cancer care, and how...
Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health, and Norah Crossnohere, PhD, the Ohio State University College of Medicine, discuss their work on implementing patient-reported outcome measures into cancer care, and how...
Claire Snyder, PhD, Johns...
08/30/2023
Journal of Clinical Pathways

Newsfeed

News
GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine
06/10/2024
Grace Taylor, MS, MA
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare...
06/10/2024
Journal of Clinical Pathways
AI
News
The Potential for AI in Oncology
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
Amy Valley and the AI panel from CPC+CBEx.
News
AI in Cancer Care: Navigating the Current Landscape and Future Possibilities
10/24/2023

Brandon Twyford

Brandon Twyford
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care:...
10/24/2023
Journal of Clinical Pathways
News
For Patients at High Risk of Hereditary Cancer, Automated Alerts in EHRs May Increase Rates of Genetic Testing, But Implementation Barriers Impede Their Use
05/27/2022

Ellen Kurek

Ellen Kurek
Automated alerts providing recommendations in the electronic health record were shown to increase the rate of compliance with such recommendations by 5% to 10%.
Automated alerts providing recommendations in the electronic health record were shown to increase the rate of compliance with such recommendations by 5% to 10%.
Automated alerts providing...
05/27/2022
Journal of Clinical Pathways
News
Artificial Intelligence-Powered Spatial Analysis of TILs Predicts Treatment Outcomes With ICIs in NSCLC
05/16/2022

Ellen Kurek

Ellen Kurek
Researchers developed a whole-slide image analyzer powered by artificial intelligence that could detect three immune phenotypes that correlated with treatment outcomes to immune checkpoint inhibitors among patients with NSCLC.
Researchers developed a whole-slide image analyzer powered by artificial intelligence that could detect three immune phenotypes that correlated with treatment outcomes to immune checkpoint inhibitors among patients with NSCLC.
Researchers developed a...
05/16/2022
Journal of Clinical Pathways
News
Implementing an EHR-Integrated Symptom and Needs Screening and Referral System for Spanish-Speaking Oncology Patients
04/14/2022

Ellen Kurek

Ellen Kurek
Study findings demonstrate encouraging feasibility and initial acceptability of implementing an EHR-integrated symptom and needs screening and referral system among diverse oncology patients.
Study findings demonstrate encouraging feasibility and initial acceptability of implementing an EHR-integrated symptom and needs screening and referral system among diverse oncology patients.
Study findings demonstrate...
04/14/2022
Journal of Clinical Pathways
News
Interactive Data Visualization Tool Facilitates Shared Decision-Making in Kidney Cancer
09/21/2021
Researchers developed an interactive visualization tool for kidney cancer with the potential to facilitate shared decision-making between patients and providers.
Researchers developed an interactive visualization tool for kidney cancer with the potential to facilitate shared decision-making between patients and providers.
Researchers developed an...
09/21/2021
Journal of Clinical Pathways
News
Managing Inpatient and Outpatient Cancer Care During a Cyberattack
08/31/2021
A recent article detailing a cyberattack on the University of Vermont Health Network discusses the impact the attack had on cancer care delivery and offers advice on oncology practices that can be implemented to lessen the impact of a...
A recent article detailing a cyberattack on the University of Vermont Health Network discusses the impact the attack had on cancer care delivery and offers advice on oncology practices that can be implemented to lessen the impact of a...
A recent article detailing a...
08/31/2021
Journal of Clinical Pathways
News
ASCO Releases Standards for Telehealth in Oncology
08/25/2021
An expert panel developed standards and guidance for oncology clinicians who are utilizing telehealth for their patients.
An expert panel developed standards and guidance for oncology clinicians who are utilizing telehealth for their patients.
An expert panel developed...
08/25/2021
Journal of Clinical Pathways
News
Efficiency and Safety of Telehealth vs In-Person Care for Patients With Cancer
07/29/2021
The utilization of telehealth in oncology does not lead to worse efficiency or outcomes for patients, when compared with in-person care.
The utilization of telehealth in oncology does not lead to worse efficiency or outcomes for patients, when compared with in-person care.
The utilization of telehealth in...
07/29/2021
Journal of Clinical Pathways
News
Examining Treatment Delay Trends in Patients With Lung Cancer
07/24/2024
A study in Missouri uncovers a disturbing trend of increasing delays in lung cancer treatment initiation, surpassing national guidelines and prompting a call for further investigation into potential causes.
A study in Missouri uncovers a disturbing trend of increasing delays in lung cancer treatment initiation, surpassing national guidelines and prompting a call for further investigation into potential causes.
A study in Missouri uncovers a...
07/24/2024
Journal of Clinical Pathways
News
First-Line Amivantamab Plus Lazertinib Superior to Osimertinib Among Patients With Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
07/18/2024
Results from the phase 3 MARIPOSA study found that first-line amivantamab plus lazertinib demonstrated superior efficacy compared to osimertinib among patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer.
Results from the phase 3 MARIPOSA study found that first-line amivantamab plus lazertinib demonstrated superior efficacy compared to osimertinib among patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer.
Results from the phase 3...
07/18/2024
Oncology
News
Perioperative Nivolumab Prolonged Event-Free Survival Compared to Perioperative Chemotherapy Among Patients With Resectable Non-Small Cell Lung Cancer
07/15/2024
Results from the phase 3 CheckMate 77T trial demonstrated that perioperative nivolumab prolonged event-free survival compared to perioperative chemotherapy among patients with resectable non-small cell lung cancer.
Results from the phase 3 CheckMate 77T trial demonstrated that perioperative nivolumab prolonged event-free survival compared to perioperative chemotherapy among patients with resectable non-small cell lung cancer.
Results from the phase 3...
07/15/2024
Oncology
News
Improving Care for Patients With Cancer Through Early Goal of Care Discussions
07/03/2024
Standardizing electronic documentation of physician-led goals of care discussions in patients with cancer can lead to improved care integration across health care settings, ensuring comprehensive and individualized quality care for patients...
Standardizing electronic documentation of physician-led goals of care discussions in patients with cancer can lead to improved care integration across health care settings, ensuring comprehensive and individualized quality care for patients...
Standardizing electronic...
07/03/2024
Journal of Clinical Pathways
Conference Coverage
The Association Between High Deductible Health Plans and Cancer Survival
07/02/2024
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
According to findings presented...
07/02/2024
Journal of Clinical Pathways
News
Impact of Care Delays on Health Care Resource Utilization in Patients With Early-Stage Lung Cancer
06/26/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
06/26/2024
Journal of Clinical Pathways
News
GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine
06/10/2024
Grace Taylor, MS, MA
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare...
06/10/2024
Journal of Clinical Pathways
News
Phase 3 KEYNOTE-522 Trial Meets Overall Survival Endpoints in Patients With TNBC
05/30/2024
Grace Taylor, MS, MA
Merck announced that their phase 3 KEYNOTE-522 trial evaluating pembrolizumab (Keytruda) met its overall survival endpoint for treating patients with high-risk early-state triple-negative breast cancer (TNBC).
Merck announced that their phase 3 KEYNOTE-522 trial evaluating pembrolizumab (Keytruda) met its overall survival endpoint for treating patients with high-risk early-state triple-negative breast cancer (TNBC).
Merck announced that their phase...
05/30/2024
Journal of Clinical Pathways
News
Ajax Therapeutics Receives FDA Clearance to Initiate Phase 1 Clinical Study of AJ1-11095 for Myelofibrosis
05/23/2024
Grace Taylor, MS, MA
Ajax Therapeutics received clearance from the US Food and Drug Administration (FDA) to begin a phase 1 clinical study of AJ1-11095, a first-in-class type 2 JAK2 inhibitor, for treating myelofibrosis.
Ajax Therapeutics received clearance from the US Food and Drug Administration (FDA) to begin a phase 1 clinical study of AJ1-11095, a first-in-class type 2 JAK2 inhibitor, for treating myelofibrosis.
Ajax Therapeutics received...
05/23/2024
Journal of Clinical Pathways
News
Patients With Breast Cancer Experience High Economic Burden and Lower HRQoL: Literature Review
05/15/2024
Grace Taylor, MS, MA
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review...
05/15/2024
Journal of Clinical Pathways

Conference Coverage

AI
News
The Potential for AI in Oncology
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
Best Practices in Care Team Communication Technology: Updates From NCCN 2024
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Nate Wade, PharmD.
Videos
EHR Integration: Strategies to Enhance Precision Medicine
03/25/2024

Featuring Nate Wade, PharmD, MBA, BCOP

Featuring Nate Wade, PharmD, MBA, BCO...
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate...
03/25/2024
Journal of Clinical Pathways
Amy Valley and the AI panel from CPC+CBEx.
News
AI in Cancer Care: Navigating the Current Landscape and Future Possibilities
10/24/2023

Brandon Twyford

Brandon Twyford
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care:...
10/24/2023
Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
The Future of AI in Cancer Care
10/08/2023

Featuring Will Shapiro

Featuring Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
James Hamrick, MD, MPH
Interview
Improving Patient Care Through AI Clinical Decision Support Tools
03/21/2023
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH,...
03/21/2023
Journal of Clinical Pathways
Rebecca Maniago, PharmdD, BCOP
Interview
The Value of AI-Enabled Clinical Decision Support Tools in Clinical Pathways
03/20/2023
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP,...
03/20/2023
Journal of Clinical Pathways
Matthew Lunning, DO, FACP
Videos
Telehealth Utilization in Clinical Trial Research and Participation
10/27/2022
Matthew Lunning, DO, FACP, discusses the expansion of telehealth during the “COVID era,” highlighting the importance of face-to-face encounters between patients and health care providers, and suggesting ways to successfully meet this demand...
Matthew Lunning, DO, FACP, discusses the expansion of telehealth during the “COVID era,” highlighting the importance of face-to-face encounters between patients and health care providers, and suggesting ways to successfully meet this demand...
Matthew Lunning, DO, FACP,...
10/27/2022
Journal of Clinical Pathways
Conference Coverage
PRO-Based Symptom Management Shows Links to Improved Clinical Outcomes
09/30/2022

Craig Ostroff

Craig Ostroff
Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...
Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...
Randomized controlled trials at...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
New Tools to Improve Clinical Decision Making and Patient Support
03/05/2022

Marta Rybczynski

Marta Rybczynski
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought on a panel showcasing products and services that improve clinical making and patient support, featuring platforms from Elsevier, GE Medical, Flatiron Assist,...
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought on a panel showcasing products and services that improve clinical making and patient support, featuring platforms from Elsevier, GE Medical, Flatiron Assist,...
A session at the ACCC 48th...
03/05/2022
Journal of Clinical Pathways
Laura Bray
Videos
Advocacy to Reduce the Impact of Drug Shortages on Cancer Care
07/23/2024
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her...
07/23/2024
Journal of Clinical Pathways
Steve Kalloger, MSc
Videos
Trends in Therapeutic Utilization Among Patients With CLL: Results From the Lymphoma Coalition’s 2022 Global Patient Survey Presented at ASCO 2024
07/18/2024
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses...
07/18/2024
Journal of Clinical Pathways
Stephen Colvill, MBA
Conference Coverage
How Collaboration Among Health Care Stakeholders Can Help Mitigate Drug Shortages
07/08/2024
Stephen Colvill, MBA, discusses how collaboration, proactive strategies, and technology can help prevent drug shortages.
Stephen Colvill, MBA, discusses how collaboration, proactive strategies, and technology can help prevent drug shortages.
Stephen Colvill, MBA, discusses...
07/08/2024
Journal of Clinical Pathways
Conference Coverage
The Association Between High Deductible Health Plans and Cancer Survival
07/02/2024
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
According to findings presented at ASCO 2024, researchers found that high deductible health plans are associated with worse survival in cancer survivors.
According to findings presented...
07/02/2024
Journal of Clinical Pathways
News
Impact of Care Delays on Health Care Resource Utilization in Patients With Early-Stage Lung Cancer
06/26/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
06/26/2024
Journal of Clinical Pathways
Moritz Furstenau, MD
Conference Coverage
Efficacy and ctDNA Analysis of MRD-Guided Acalabrutinib, Venetoclax, and Obinutuzumab for Patients With R/R CLL
06/26/2024

Featuring Moritz Furstenau, MD

Featuring Moritz Furstenau, MD ...
At the 65th ASH Annual Meeting, Moritz Furstenau, MD, presented a follow-up analysis of the CLL2-Baag trial on the efficacy and ctDNA analysis of acalabrutinib, venetoclax, and obinutuzumab combination therapy after optional debulking with...
At the 65th ASH Annual Meeting, Moritz Furstenau, MD, presented a follow-up analysis of the CLL2-Baag trial on the efficacy and ctDNA analysis of acalabrutinib, venetoclax, and obinutuzumab combination therapy after optional debulking with...
At the 65th ASH Annual Meeting,...
06/26/2024
Oncology
Tony Mok, MD
Conference Coverage
Adagrasib Improved Survival and Response Among Patients With KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
06/17/2024
Tony Mok, MD
According to results from the phase 3 KRYSTAL-12 trial, adagrasib improved survival and response compared to docetaxel among patients with previously treated KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer.
According to results from the phase 3 KRYSTAL-12 trial, adagrasib improved survival and response compared to docetaxel among patients with previously treated KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer.
According to results from the...
06/17/2024
Oncology
William J. Gradishar, MD
Videos
HR-Positive and HER2-Negative Breast Cancer Treatment Updates
06/04/2024
William J. Gradishar, MD
William J. Gradishar, MD, details the latest advancements in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) breast cancer.
William J. Gradishar, MD, details the latest advancements in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) breast cancer.
William J. Gradishar, MD,...
06/04/2024
Journal of Clinical Pathways
Natasha Leighl, MD
Conference Coverage
Subcutaneous vs Intravenous Amivantamab Plus Lazertinib for Patients With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
06/01/2024
Natasha Leighl, MD
Natasha Leighl, MD, discussed results from the phase 3 PALOMA-3 trial which compared subcutaneous and intravenous amivantamab plus lazertinib in patients with advanced, EGFR-mutated non-small cell lung cancer.
Natasha Leighl, MD, discussed results from the phase 3 PALOMA-3 trial which compared subcutaneous and intravenous amivantamab plus lazertinib in patients with advanced, EGFR-mutated non-small cell lung cancer.
Natasha Leighl, MD, discussed...
06/01/2024
Oncology
Lalan Wilfong, MD
Videos
Balancing the Benefits and Risks of Value-Based Care Arrangements
05/16/2024
Lalan Wilfong, MD
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his...
05/16/2024
Journal of Clinical Pathways

Expert Insights

Robert Stillman, MA, RN
Videos
Best Practices in Care Team Communication Technology: Updates From NCCN 2024
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Nate Wade, PharmD.
Videos
EHR Integration: Strategies to Enhance Precision Medicine
03/25/2024

Featuring Nate Wade, PharmD, MBA, BCOP

Featuring Nate Wade, PharmD, MBA, BCO...
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate...
03/25/2024
Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
The Future of AI in Cancer Care
10/08/2023

Featuring Will Shapiro

Featuring Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
Video preview thumbnail.
Videos
AI Technology in Oncology Care: Thoughts From The Oncology Institute
10/02/2023

Featuring Daniel Virnich, MD; Yale Podnos, MD; and Nikhil Buduma

Featuring Daniel Virnich, MD; Yale Po...
Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...
Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...
Daniel Virnich, MD, CEO of The...
10/02/2023
Journal of Clinical Pathways
Video preview image.
Videos
St. Elizabeth’s Innovative Cancer Screening Outreach Model
09/22/2023

Featuring Michael Gieske, MD, and Jamie Ries, RN, BSN

Featuring Michael Gieske, MD, and Jam...
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie...
09/22/2023
Journal of Clinical Pathways
Stephen Edge, MD.
Videos
Clinical Pathways in Practice at Roswell Park Cancer Center
09/05/2023

Featuring Stephen Edge, MD

Featuring Stephen Edge, MD
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president...
09/05/2023
Journal of Clinical Pathways
Video thumbnail screenshot.
Videos
Using Digital Health to Implement Patient-Reported Outcomes in Cancer Care
08/30/2023

Featuring Claire Snyder, PhD, and Norah Crossnohere, PhD

Featuring Claire Snyder, PhD, and Nor...
Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health, and Norah Crossnohere, PhD, the Ohio State University College of Medicine, discuss their work on implementing patient-reported outcome measures into cancer care, and how...
Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health, and Norah Crossnohere, PhD, the Ohio State University College of Medicine, discuss their work on implementing patient-reported outcome measures into cancer care, and how...
Claire Snyder, PhD, Johns...
08/30/2023
Journal of Clinical Pathways
James Hamrick, MD, MPH
Interview
Improving Patient Care Through AI Clinical Decision Support Tools
03/21/2023
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH,...
03/21/2023
Journal of Clinical Pathways
Rebecca Maniago, PharmdD, BCOP
Interview
The Value of AI-Enabled Clinical Decision Support Tools in Clinical Pathways
03/20/2023
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP,...
03/20/2023
Journal of Clinical Pathways
Michael Kolodziej, MD
Videos
ePROs Play a Key Role in Personalized Therapy
11/17/2022
Michael Kolodziej, MD, Advisor, Canopy, discusses at the 2022 Oncology Clinical Pathways Congress how electronic patient-reported outcomes and electronic engagement with patients can aid improve outcomes.
Michael Kolodziej, MD, Advisor, Canopy, discusses at the 2022 Oncology Clinical Pathways Congress how electronic patient-reported outcomes and electronic engagement with patients can aid improve outcomes.
Michael Kolodziej, MD, Advisor,...
11/17/2022
Journal of Clinical Pathways
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
Blog
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
08/07/2024
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together...
08/07/2024
Journal of Clinical Pathways
Farrukh Awan, MD
Videos
Chronic Lymphocytic Leukemia Treatment Updates
07/31/2024
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some of the most important advancements in chronic lymphocytic leukemia (CLL) treatment over the past 10 years.
Farrukh Awan, MD, discusses some...
07/31/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Why People Should Care About How Health Care Works (Part 1)
07/29/2024
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part...
07/29/2024
Cancer Care Business Exchange
Ivy Altomare, MD
Videos
Characteristics of Clinical Trials in Community Oncology Practices Across the US
07/23/2024
Ivy Altomare, MD, provides an overview of her study on the characteristics of clinical trials carried out in community oncology practices within the Flatiron Health network in the US.
Ivy Altomare, MD, provides an overview of her study on the characteristics of clinical trials carried out in community oncology practices within the Flatiron Health network in the US.
Ivy Altomare, MD, provides an...
07/23/2024
Journal of Clinical Pathways
Laura Bray
Videos
Advocacy to Reduce the Impact of Drug Shortages on Cancer Care
07/23/2024
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her...
07/23/2024
Journal of Clinical Pathways
Sandip Patel, MD
Videos
Recent Advancements in the Non–Small Cell Lung Cancer Treatment Landscape
07/22/2024
Sandip Patel, MD, discusses the latest updates in the non–small cell lung cancer (NSCLC) treatment landscape.
Sandip Patel, MD, discusses the latest updates in the non–small cell lung cancer (NSCLC) treatment landscape.
Sandip Patel, MD, discusses the...
07/22/2024
Journal of Clinical Pathways
Steve Kalloger, MSc
Videos
Trends in Therapeutic Utilization Among Patients With CLL: Results From the Lymphoma Coalition’s 2022 Global Patient Survey Presented at ASCO 2024
07/18/2024
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses the results from the Lymphoma Coalition’s 2022 Global Patient Survey regarding therapeutic utilization trends among patients with chronic lymphocytic leukemia (CLL).
Steve Kalloger, MSc, discusses...
07/18/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
Show Me the Medical Evidence
07/15/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health...
07/15/2024
Cancer Care Business Exchange
Gunjan Sharma
Interview
Leveraging Data to Enhance Patient Care: Addressing Social Determinants of Health in Oncology Care
07/10/2024
US Oncology Network analyst Gunjan Sharma shares insights on the impact of health-related social needs, Beer’s criteria medication prescribing patterns, and how research can inform the development of support services for patients with cancer.
US Oncology Network analyst Gunjan Sharma shares insights on the impact of health-related social needs, Beer’s criteria medication prescribing patterns, and how research can inform the development of support services for patients with cancer.
US Oncology Network analyst...
07/10/2024
Journal of Clinical Pathways
Stephen Colvill, MBA
Conference Coverage
How Collaboration Among Health Care Stakeholders Can Help Mitigate Drug Shortages
07/08/2024
Stephen Colvill, MBA, discusses how collaboration, proactive strategies, and technology can help prevent drug shortages.
Stephen Colvill, MBA, discusses how collaboration, proactive strategies, and technology can help prevent drug shortages.
Stephen Colvill, MBA, discusses...
07/08/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Recent Stories

News
GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine
06/10/2024
Grace Taylor, MS, MA
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare...
06/10/2024
Journal of Clinical Pathways
AI
News
The Potential for AI in Oncology
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
Best Practices in Care Team Communication Technology: Updates From NCCN 2024
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Nate Wade, PharmD.
Videos
EHR Integration: Strategies to Enhance Precision Medicine
03/25/2024

Featuring Nate Wade, PharmD, MBA, BCOP

Featuring Nate Wade, PharmD, MBA, BCO...
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate...
03/25/2024
Journal of Clinical Pathways
Amy Valley and the AI panel from CPC+CBEx.
News
AI in Cancer Care: Navigating the Current Landscape and Future Possibilities
10/24/2023

Brandon Twyford

Brandon Twyford
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care:...
10/24/2023
Journal of Clinical Pathways

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement